Physician profile
Michael A Lucci
NPI 1598731622
$6,381.01
in general payments reported to CMS, 2019-2025
12 companies · $1,531 in 2025
The $1,531 reported for 2025 was more than what 87% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $577 · 2022: $1,207 · 2023: $1,431 · 2024: $1,634 · 2025: $1,531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,596.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $2,043.05 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $1,762.21 | 2021-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System, Endocross Device |
| Medtronic, INC. | $1,361.88 | 2023-2025 | Endurant Iis, In.Pact Admiral, Valiant Captivia |
| Boston Scientific Corporation | $625.73 | 2025 | Enroute Transcarotid Neuroprotection System, Enhance Transcarotid Peripheral Access Kit, Enroute Transcarotid Stent |
| Veryan Medical Incorporated | $189.11 | 2022 | |
| Abiomed | $106.63 | 2023-2025 | Impella |
| W. L. Gore & Associates, INC. | $104.97 | 2021 | |
| Smith+Nephew, INC. | $97.89 | 2023-2025 | Renasys Go V2 Home, Collagenase Santyl |
| Lemaitre Vascular, INC. | $37.48 | 2023-2025 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome |
| Atricure, INC. | $23.51 | 2024 | |
| Getinge USA Sales, LLC | $15.38 | 2023 | Vasoview Hemopro 2 |
| Livanova USA, INC. | $13.17 | 2023 | Lifesparc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.